MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Executive functions"

  • 2018 International Congress

    Effects of computerized cognitive training, with and without concurrent exercise, on executive functions in Parkinson’s disease

    M. Fernandez-del-Olmo, JA. Sánchez-Molina, H. Fernandez-Lago, L. Morenilla-Burlo, J. Gómez-Varela, N. Fogelson (A Coruña, Spain)

    Objective: To explore the effect cognitive training group vs cognitive training with concurrent physical exercise group on executive functions in Parkinson's Disease. Background: PD patients…
  • 2018 International Congress

    Biomarkers of rapid progression of cognitive decline in Parkinson’s disease

    S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, J. Marin-Lahoz, A. Horta-Barba, H. Bejr-Kasem, I. Aracil, J. Perez-Perez, MA. Boti, J. Kulisevsky. (Barcelona, Spain)

    Objective: We aimed to explore cross-sectional grey-matter volume (GMV) and CSF biomarkers differences in PD patients exhibiting a rapid progression of cognitive decline compared to…
  • 2018 International Congress

    New approach to assess changes in brain activation during real walking using EEG

    I. Maidan, S. Shustak, T. Shiner, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the use of EEG during the performance of two well-known paradigms, dual task and oddball, to reveal changes in brain activation during…
  • 2018 International Congress

    The neural effects of a randomized controlled cognitive training program for treating freezing of gait in Parkinson’s disease

    M. Gilat, C. Walton, L. Mowszowski, J. Shine, J. Hall, M. Georgiades, A. Muller, C. O'Callaghan, K. Ehgoetz Martens, J. Szeto, S. Naismith, S. Lewis (Sydney, Australia)

    Objective: This study set out to investigate whether a targeted cognitive training program (CT) induced neural plasticity processes associated with reduced propensity for freezing of…
  • 2017 International Congress

    Fluency boost from walking in Parkinson’s disease

    O. Barthelemy, R. Salazar, S. Neargarder, J. DeGutis, T. Ellis, A. Cronin-Golomb (Boston, MA, USA)

    Objective: Examine the impact of a motor task on verbal fluency in individuals with Parkinson’s disease (PD) Background: Dual-tasking, in which individuals engage simultaneously in…
  • 2017 International Congress

    Relationship between neuropsychological functioning and subjective measures of sleep quality in Parkinson Disease

    E. Montanaro, M. Zibetti, F. Dematteis, L. Lopiano (Torino, Italy)

    Objective: To analyze the relationship between subjectively reported sleep alterations and cognitive functions in a large series of advanced Parkinson Disease (PD) patients evaluated with…
  • 2017 International Congress

    Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

    J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

    Objective: To determine whether Parkinson's disease patients with mild cognitive impairment (PD-MCI) demonstrate more accurate self-appraisals of their cognitive deficits than non-PD individuals with amnestic…
  • 2017 International Congress

    Emotion regulation and neuropsychological status in psychogenic subtypes.

    B. Scott, A. Strutt, P. Lundberg-Love, A. Schmitt, J. Jankovic, D. Bowers (Gainesville, FL, USA)

    Objective: To determine whether cognitive dysfunction is associated with emotion regulation strategies and psychological distress in two psychogenic movement disorder (PMD) variants: non-epileptic seizures (PNES)…
  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

    H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)

    Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley